|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.03 CNY | -4.45% |
|
-10.17% | -18.44% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 41.58B 5.86B | P/E ratio 2024 * |
30.1x | P/E ratio 2025 * | 25.4x |
|---|---|---|---|---|---|
| Enterprise value | 50.98B 7.19B | EV / Sales 2024 * |
6.1x | EV / Sales 2025 * | 5.01x |
| Free-Float |
45.42% | Yield 2024 * |
0.64% | Yield 2025 * | 0.75% |
More valuation ratios
* Estimated data
More news
| 1 day | -4.45% | ||
| 1 week | -10.17% | ||
| Current month | -11.53% | ||
| 1 month | -14.09% | ||
| 3 months | -18.49% | ||
| 6 months | -11.17% | ||
| Current year | -18.44% |
1 week
20.72
23.36
1 month
20.7224.85
Current year
20.1727.05
1 year
20.1727.28
3 years
12.4427.28
5 years
12.4437.15
10 years
5.7137.15
| Director | Title | Age | Since |
|---|---|---|---|
Bo Tian
IRC | Investor Relations Contact | - | 06-02-28 |
Xiang Ci
SEC | Corporate Secretary | 45 | 02-12-31 |
Yi Zhang
PRN | Corporate Officer/Principal | 54 | 99-12-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hui Chuan Yang
CHM | Chairman | 57 | 11-05-31 |
Li Gang Hu
BRD | Director/Board Member | 50 | 17-05-24 |
Jing Jin Zhu
CHM | Chairman | 62 | 16-10-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.66% | 1 M€ | -20.08% | - | |
| 0.61% | 2 M€ | -14.14% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -4.45% | -10.17% | -1.04% | -10.06% | 5.86B | ||
| -0.64% | -1.93% | +10.69% | -4.34% | 96.82B | ||
| +1.96% | -0.60% | +35.43% | +6.11% | 53.39B | ||
| -3.41% | -1.34% | +88.66% | +72.10% | 34.7B | ||
| -0.69% | -1.21% | -22.21% | -33.97% | 29.07B | ||
| +0.99% | -16.85% | -19.98% | -9.27% | 13.3B | ||
| +1.11% | +4.75% | +387.79% | +379.25% | 12.86B | ||
| +0.03% | +5.23% | +6.20% | -12.58% | 12.79B | ||
| -0.03% | -1.03% | +39.61% | -27.77% | 12.13B | ||
| +0.18% | +4.79% | +48.35% | +38.53% | 11.15B | ||
| Average | -0.50% | -1.20% | +57.35% | +39.80% | 28.21B | |
| Weighted average by Cap. | -0.33% | -0.32% | +39.61% | +21.44% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 6.13B 865M | 7.22B 1.02B |
| Net income | 1.38B 194M | 1.65B 232M |
| Net Debt | -4.16B -586M | -5.46B -770M |
More financial data
* Estimated data
Employees
4,858
Sector
Pharmaceuticals
Calendar
2024-10-23
- Q3 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-09-13 | 21.03 ¥ | -4.45% | 27,421,380 |
| 24-09-12 | 22.01 ¥ | -5.37% | 14,020,050 |
| 24-09-11 | 23.26 ¥ | -0.64% | 3,656,900 |
| 24-09-10 | 23.41 ¥ | -0.76% | 6,560,575 |
End-of-day quote Shanghai S.E., September 12, 2024
More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
21.03CNY
Average target price
29.92CNY
Spread / Average Target
+42.29%
- Stock Market
- Equities
- 600161 Stock